LUMAKRAS is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Sotorasib.
| Product ID | 55513-488_3b378de2-ac6e-4f2b-9d8a-9ea72f0f9374 |
| NDC | 55513-488 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LUMAKRAS |
| Generic Name | Sotorasib |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-05-28 |
| Marketing Category | NDA / |
| Application Number | NDA214665 |
| Labeler Name | Amgen Inc |
| Substance Name | SOTORASIB |
| Active Ingredient Strength | 120 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-05-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LUMAKRAS 97248835 not registered Live/Pending |
Amgen Inc. 2022-02-01 |
![]() LUMAKRAS 90532537 not registered Live/Pending |
Amgen Inc, 2021-02-17 |
![]() LUMAKRAS 90044720 not registered Live/Pending |
Amgen Inc. 2020-07-09 |